Ignite Creation Date:
2025-12-24 @ 11:51 PM
Ignite Modification Date:
2025-12-25 @ 9:46 PM
Study NCT ID:
NCT01364051
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-09-10
First Post:
2011-05-26
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Cediranib Maleate and Selumetinib Sulfate in Treating Patients With Solid Malignancies
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-05-25
Start Date Type:
ACTUAL
Primary Completion Date:
2019-06-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-03-19
Completion Date Type:
ESTIMATED
First Submit Date:
2011-05-26
First Submit QC Date:
None
Study First Post Date:
2011-06-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-09
Last Update Post Date:
2025-09-10
Last Update Post Date Type:
ESTIMATED